Monday, January 9, 2017

Regeneron CEO says Amgen not putting patients first in patent dispute

Jan 9 (Reuters) - Regeneron Pharmaceuticals Chief

Executive Len Schliefer on Monday ripped into Amgen Inc

for its insistence on blocking sales of a rival Regeneron

cholesterol drug while the appeals...

Read more
Posted by at

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)